We’re excited to share that new companies are joining the ENMC Company Forum in 2026! A warm welcome to argenx and Avidity Biosciences, Inc., who will be joining our valued partners: Amicus Therapeutics International, Dyne Therapeutics, Lupin Pharmaceuticals, Novartis, Roche, Sanofi, Santhera Pharmaceuticals, and Sarepta Therapeutics. We are deeply grateful for the continued and growing […]
We are thrilled to announce that FSHD Europe has joined as an Associated Partner of the ENMC in 2026, alongside the Österreichische Muskelforschung, SMA Europe, TREAT-NMD, the World Duchenne Organization, and the World Muscle Society. We are grateful for their support in advancing our mission of ‘Connecting People’ within the Neuromuscular field!
In the fifth call for the ENMC Mid-Career Mentoring Programme with the deadline July 2025, we received eight applications! Following interviews with each of the candidates, the ENMC Mentoring Programme Committee presented their recommendations to the Research- and Executive Committees. We are very happy to announce that six mentee candidates were selected for the programme: Teresa […]
On 1 July 2025, the ENMC welcomed two new Research Committee (RC) members, Prof. Kristl Claeys (Laboratory for Muscle Diseases and Neuropathies, UZ Leuven, Belgium) and Prof. Charlotte Handberg (National Rehabilitation Center for Neuromuscular Diseases (RCFM), Aarhus, Denmark). On 13 November, the RC came together for the autumn Research Committee meeting held at the World Trade Center Schiphol, the […]
The ENMC had an inspiring and productive time at the World Muscle Society Congress in Vienna, connecting with clinicians, researchers, and experts from across the neuromuscular field. It was a great opportunity to meet with ENMC workshop organisers and participants, (former) ENMC Executive & Research Committee members and (potential) Company Forum partners — and we’re […]
We are proud to present the ENMC Impact Report 2024! Read about our 2024 activities via this link. If you would like to receive a printed copy, please send your request to enmc@enmc.org.
ENMC is happy to announce that 4 workshop applications have been approved in the 2025 Spring review round. These workshops will be planned in Q1 2026. More details: Workshops 2025-2026
We are thrilled to announce that TREAT-NMD has joined as an Associated Partner of the ENMC in 2025, alongside the Österreichische Muskelforschung, SMA Europe, the World Duchenne Organization, and the World Muscle Society. We are grateful for their support in advancing our mission of ‘Connecting People’ within the Neuromuscular field!
ENMC is happy to announce that 3 workshop applications have been approved in the 2024 Autumn review round. These workshops will be planned in Q2-Q4 2025. More details: Workshops 2025
On 15 November, we said goodbye to Dr Ana Ferreiro as the ENMC Research Director, after two terms and 6 years. Ana has guided the ENMC through the Covid-19 pandemic, in finding new ways to keep the workshops afloat. The integration of the online, preparatory zoom meetings became a part of the Research Committee feedback and provided a great tool to […]
